Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
HIV-associated
100%
Placebo-controlled Trial
100%
Sensory Neuropathy
100%
Lamotrigine
100%
Antiretroviral Therapy
77%
Placebo
66%
Pain Scale
33%
Maintenance Phase
22%
Change from Baseline
22%
Adverse Events
11%
Dose Escalation
11%
Baseline Scores
11%
Rash
11%
Tolerability
11%
Clinician Rating
11%
Neuropathic Pain
11%
Pain Treatment
11%
Patient Global Impression of Change
11%
Pain Intensity
11%
Randomized Double-blind Study
11%
HIV Neuropathy
11%
Well Tolerated
11%
Patient numbers
11%
Patients with HIV
11%
Visual Analogue Pain Scale
11%
Patient Ratings
11%
Nursing and Health Professions
Human Immunodeficiency Virus
100%
Placebo
100%
Sensory Neuropathy
100%
Lamotrigine
100%
Antiretroviral Therapy
77%
Pain Assessment
22%
Adverse Event
11%
Visual Analog Scale
11%
Randomization
11%
Pain Intensity
11%
McGill Pain Questionnaire
11%
Rash
11%
Neuropathic Pain
11%
Polyneuropathy
11%
Efficacy
11%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Placebo
100%
Sensory Neuropathy
100%
Lamotrigine
100%
Antiretroviral Therapy
77%
Pain Assessment
22%
Clinician
11%
Visual Analog Scale
11%
Exanthem
11%
Polyneuropathy
11%
Neuropathic Pain
11%
Treatment of Pain
11%
McGill Pain Questionnaire
11%
Adverse Event
11%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
HIV
100%
Sensory Neuropathy
100%
Lamictal
100%
Adverse Event
11%
Rash
11%
Tolerability
11%
Neuropathic Pain
11%
Polyneuropathy
11%
Neuroscience
Placebo
100%
Human Immunodeficiency Virus
100%
Lamotrigine
100%
Neuropathy
100%
Neuropathic Pain
11%
Polyneuropathy
11%
Treatment of Pain
11%